
Methods: We conducted a retrospective cohort study of CDI from 2006-2012 across the Veterans Affairs Healthcare System. Our outcome was defined as a health-care-associated lab-identified C. difficileevent, defined as a positive lab test in a patient having at least 3 days of facility exposure in the prior 8 weeks, and occurring at least 8 weeks from a previous positive test. Individual-level risk variables included (1) age, (2) antibiotic use, and history of (3) acute or (4) long-term care stay in the prior 56 days. Facility-level predictors included (1) antibiotic use (days with therapy per 1,000 person-days), the proportion of persons with an (2) acute or (3) long-term care stay in prior 56 days, and importation of CDI cases from (4) acute or (5) long-term care per 10 000 person-days.
Results: 87 LTC and 82 AC facilities met our inclusion criteria. The incidence of CDI in LTC was 3.8 per 10,000 patient-days (n=6,766 cases) and was 17.9 per 10,000 patient-days (n=26,113 cases) in AC. LTC patients with a recent AC stay were more likely to develop CDI than those without a recent AC stay (IRR=4.81, 95%CI: 4.56, 5.07). Similarly, AC patients with a recent LTC stay were also more likely to develop CDI than those without, but to a lesser degree (IRR=1.88, 95%CI: 1.79, 1.98). Imported CDI cases were more prevalent in LTC (median=75 per 10,000 patient-days, range: 1.5-355) compared to AC (median=39, range: 0-115, p<0.001). In bivariate weighted linear regression models, importation of AC cases was a strong predictor of increased CDI incidence in LTC (R2=0.62), but importation of cases from LTC was not as strong a predictor of AC rates (R2=0.21).
Conclusion: Acute care and long-term care facilities are both impacted by importation of CDI. This research suggests that improved regional communication, and an inter-facility, coordinated approach to infection control, could help reduce CDI spread.

K. Brown,
None
See more of: Poster Abstract Session